Calendrier des promotions Geron Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise Geron Corporation
Корпорация "Герон", клиническая биофармацевтическая компания на поздней стадии, специализируется на разработке и коммерциализации методов лечения гематологических миелоидных злокачественных новообразований. Он обладает правами на иметелстат, ингибитор теломеразы в клинических испытаниях фазы 2F3, который ингибирует неконтролируемую пролиферацию злокачественных клеток-предшественников при гематологических миелоидных злокачественных опухолях, чтобы уменьшить дисфункциональную продукцию клеток крови и обеспечить восстановление нормальной продукции клеток крови. plus de détailsParamètres de base
IPO date
1996-06-30
ISIN
US3741631036
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 28.53 | 1 |
| P/BV | 7.82 | 1 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -35.32 | 0 |
| ROE | -66.09 | 0 |
| ROIC | -59.63 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.786 | 10 |
| Debt/Ratio | 0.2047 | 10 |
| Debt/Equity | 1.12 | 8 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 30332.41 | 10 |
| Rentabilité Ebitda, % | 106.74 | 10 |
| Rentabilité EPS, % | -1.7 | 0 |
Dividendes
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 1.45 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 1.39 $ | 0 $ | 0 $ | 4.32 % | 0 % | 0 % |
| common.calendar.number_days.30d | 1.42 $ | 1.19 $ | 1.48 $ | 2.11 % | 0 % | 0 % |
| common.calendar.number_days.90d | 2.39 $ | 1.18 $ | 1.82 $ | -39.33 % | 0 % | 0 % |
| common.calendar.number_days.180d | 4.06 $ | 1.18 $ | 3.93 $ | -64.29 % | 0 % | 0 % |
| common.calendar.number_days.1y | 3.48 $ | 1.18 $ | 5.09 $ | -58.33 % | 0 % | 0 % |
| common.calendar.number_days.3y | 1.41 $ | 1.18 $ | 5.09 $ | 2.84 % | 0 % | 0 % |
| common.calendar.number_days.5y | 1.64 $ | 0.99 $ | 5.09 $ | -11.59 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 0.8873 $ | 6.38 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 3.81 $ | 1.18 $ | 3.6 $ | -61.94 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
| ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
| Future Tech ETF | 0.27625 | -18.13 | 0.35 |
| Principal Healthcare Innovators ETF | 0.27625 | -3.92 | 0.35 |
| iShares Morningstar Small-Cap Growth ETF | 0.10126 | 604.45 | 0.06 |
| iShares Morningstar Small-Cap ETF | 0.0513 | 295.15 | 0.25 |
| 0,18 | 219,39 | 0,25 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Ms. Melissa A. Kelly Behrs | Executive VP of Business Operations & Chief Alliance Officer | 753.22k | 1964 (61 année) |
| Ms. Shannon Odam | Senior VP & Chief People Officer | N/A | 1975 (50 années) |
| Mr. Edward E. Koval | Executive VP & Chief Business Officer | N/A | 1962 (63 année) |
| Dr. John A. Scarlett M.D. | Chairman of the Board, President & CEO | 1.53M | 1951 (74 année) |
| Ms. Aron Feingold | Vice President of Investor Relations & Corporate Communications | N/A | |
| Dr. Faye Feller M.D. | Executive VP & Chief Medical Officer | N/A | 1983 (42 année) |
| Ms. Michelle J. Robertson | Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer | N/A | 1967 (58 années) |
| Dr. Andrew J. Grethlein Ph.D. | Executive VP & COO | 847.2k | 1964 (61 année) |
| Mr. Scott Samuels | Executive VP, Chief Legal Officer & Secretary | ||
| Mr. James Ziegler M.B.A. | Executive VP & Chief Commercial Officer |
Informations sur l'entreprise
Adresse: United States, Foster City, 919 East Hillsdale Boulevard - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: http://www.geron.com
Site web: http://www.geron.com
